Catalyst Wire Dossier Catalyst Wire Dossier

Ad-RTS-hIL-12

Adenoviral vector encoding human interleukin-12 under Rheostatic Transcriptional System · Alaunos Therapeutics
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Ad-RTS-hIL-12, covering 2025-04-16 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102 [Phase 1]

See pricing